Evidence map›Paper›PMID 28415578›Full record

ArticleOncotarget2017

High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia.

Elena Vendramini, Marco Giordan, Emanuela Giarin, Barbara Michielotto, Grazia Fazio, Gianni Cazzaniga, Andrea Biondi, Daniela Silvestri, Maria Grazia Valsecchi, Martina U Muckenthaler and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. MiRNAs in Hematopoiesis and Acute Lymphoblastic Leukemia.International journal of molecular sciences · 2023
    Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Elena VendraminiDepartment of Women's and Children's Health, University of Padova, Padova, Italy.
Marco GiordanDepartment of Women's and Children's Health, University of Padova, Padova, Italy.
Emanuela GiarinDepartment of Women's and Children's Health, University of Padova, Padova, Italy.
Barbara MichielottoDepartment of Women's and Children's Health, University of Padova, Padova, Italy.
Grazia FazioCentro Ricerca Tettamanti, Clinica Pediatrica, University of Milano-Bicocca, Monza, Italy.
Gianni CazzanigaCentro Ricerca Tettamanti, Clinica Pediatrica, University of Milano-Bicocca, Monza, Italy.
Andrea BiondiCentro Ricerca Tettamanti, Clinica Pediatrica, University of Milano-Bicocca, Monza, Italy.
Daniela SilvestriCentro Ricerca Tettamanti, Clinica Pediatrica, University of Milano-Bicocca, Monza, Italy.
Maria Grazia ValsecchiSchool of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy.
Martina U MuckenthalerDepartment of Pediatric Oncology Hematology, University of Heidelberg, Heidelberg, Germany.
Andreas E KulozikDepartment of Pediatric Oncology Hematology, University of Heidelberg, Heidelberg, Germany.
Valter GatteiClinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy.
Shai IzraeliEdmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel.
Giuseppe BassoDepartment of Women's and Children's Health, University of Padova, Padova, Italy.
Geertruy Te KronnieDepartment of Women's and Children's Health, University of Padova, Padova, Italy.
University of Milano-Bicocca · ITUniversity of Padua · ITHeidelberg University · DETel Aviv University · ILCentro di Riferimento Oncologico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ERG-related leukemia is a B cell precursor acute lymphoblastic leukemia (BCP ALL) subtype characterized by aberrant expression of DUX4 and ERG transcription factors, and highly recurrent ERG intragenic deletions. ERG-related patients have remarkably favorable outcome despite a high incidence of inauspicious IKZF1 aberrations.We describe clinical and genomic features of the ERG-related cases in an unselected cohort of B-other BCP ALL pediatric patients enrolled in the AIEOP ALL 2000 therapeutic protocol. We report a small noncoding RNA signature specific of ERG-related group, with up-regulation of miR-125b-2 cluster on chromosome 21 and several snoRNAs in the Prader-Willi locus at 15q11.2, including the orphan SNORD116 cluster.

Indexed as

Gene ExpressionMultigene FamilyAdolescentAntineoplastic AgentsBiomarkersChildChild, PreschoolChromosome AberrationsChromosomes, Human, Pair 15Chromosomes, Human, Pair 21Cohort StudiesFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansInfantAntineoplastic AgentsBiomarkersMicroRNAsMIRN125 microRNA, humanRNA, Small NucleolarSNORD116 RNA, humanTranscriptional Regulator ERGB cell precursor acute lymphoblastic leukemiaERG aberrationsmiR-125noncoding RNAsSNORD116

Identifiers

PMID28415578
PMCPMC5522075
OpenAlexW2598447158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.